Replies to post #23189 on Cytodyn Inc (CYDY)

[finesand]

gestalt- the p value and foremost the upcoming poster will show us the real impact of the data

Also the scientific community and BP couldn't care less about a PR, but only value the actual data.

Regardless, our SP is - as we know - far too much below any reasonable evaluation for today.
So yes, let's catch up with 90c, as of 2/20 PR and close the gap and stay above it. Then let's have upcoming conclusions appreciate underlying value better.

Just my 2c, not here for a daily swing anyways.

[Northstar42]

Gestalt, here is something new from the ASM Poster - "A roll-over study, PRO 140 CD02-Extension, was designed to extend a subject's access to PRO 140 treatment when, in the opinion of the treating physician, PRO 140 was required to form a viable suppressive regimen."

Of critical significance is that...."To date, 35 subjects have entered the extension study."